Stay updated with breaking news from Worst Itch Numeric Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investigational roflumilast cream 0.05% met the primary endpoint and all secondary endpoints, showing significant improvement across multiple efficacy endpoints as early as Week 139.4% of children...
Investigational roflumilast cream 0.05% met the primary endpoint and all secondary endpoints, showing significant improvement ...
Investigational roflumilast cream 0.05% met the primary endpoint and all secondary endpoints, showing significant improvement across multiple efficacy endpoints as early as Week 139.4% of children...
19.09.2023 - Study met the primary endpoint and all secondary endpoints, highly consistent with rapid response from the INTEGUMENT-1 and INTEGUMENT-2 pivotal trialsFor the primary endpoint, 25.4% of children treated once daily with roflumilast cream 0.05% ... Seite 1
A supplemental New Drug Application will be submitted for roflumilast cream 0.05% for the treatment of mild to moderate atopic dermatitis in children 2 to 5 years of age.